[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Celldex Therapeutics, Inc (CLDX)
Celldex Therapeutics (CLDX) is seeing increased social media engagement with positive sentiment. Despite the positive sentiment, the stock price is experiencing slight downward pressure.
About Celldex Therapeutics, Inc
Celldex Therapeutics, Inc. (CLDX) is a publicly traded healthcare company.
Celldex Therapeutics, Inc uses the ticker $CLDX for trading. Listed in the Stocks and category within the Healthcare sectors.
Insights #
- Celldex Therapeutics, Inc (CLDX) trading volume is up XXXXX% from the previous week.
- Celldex Therapeutics, Inc (CLDX) social dominance is up XXXXXX% from the previous week.
- Celldex Therapeutics, Inc (CLDX) galaxy score™ is up XXXXX% from the previous week.
- Celldex Therapeutics, Inc (CLDX) creators is up XXX% from the previous X months.
- Celldex Therapeutics, Inc (CLDX) mentions is up XXXXXX% from the previous X months.
Price: $XXXXX #
Price 24-Hour Chart Data
The stock price is experiencing slight downward pressure, likely due to mixed market sentiment despite a positive 24-hour price change. The social media posts mentioning both high potential and market concerns support this view.
| 24-Hour | 7-Day | 30-Day |
|---|---|---|
| XXXX% | XXXX% | XXXXX% |
1-Year High: $XXXXX on 2024-09-04
1-Year Low: $XXXXX on 2025-04-08
AltRank: XXX #
AltRank 24-Hour Chart Data
Celldex Therapeutics, Inc (CLDX) is currently AltRank #853 based on combined combined social and market metrics
Daily Average: XXX
1 Week: XXXXX +468
1 Month: XXX -XXXXX
6 Months: XXX -XXX
1 Year: XXX +205
1-Year High: XXXXX on 2025-06-29
1-Year Low: XX on 2024-09-28
Galaxy Score: XXXXX #
Galaxy Score 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX +6
1 Month: XX -XX
6 Months: XX -XX
1 Year: XX +5
1-Year High: XX on 2025-04-11
1-Year Low: XX on 2024-10-13
Engagements: XXX #
Engagements 24-Hour Chart Data
Current Value: XXX
Daily Average: XXXXX
1 Week: XXXXXX -XXXX%
1 Month: XXXXXX -XX%
6 Months: XXXXXXX -XX%
1 Year: XXXXXXXXX -XX%
1-Year High: XXXXXX on 2024-09-26
1-Year Low: XX on 2024-12-27
| Social Network | X | |
|---|---|---|
| Engagements | XXX | X |
Mentions: XX #
Mentions 24-Hour Chart Data
Current Value: XX
Daily Average: XX
1 Week: XXX +23%
1 Month: XXX +82%
6 Months: XXXXX +2.30%
1 Year: XXXXX +127%
1-Year High: XXX on 2025-06-27
1-Year Low: X on 2025-01-27
| Social Network | X | |
|---|---|---|
| Mentions | XXX | X |
Creators: XX #
Creators 24-Hour Chart Data
XX unique social accounts have posts mentioning Celldex Therapeutics, Inc (CLDX) in the last XX hours which is no change from in the previous XX hours
Daily Average: XX
1 Week: XXX +14%
1 Month: XXX +105%
6 Months: XXX +44%
1 Year: XXXXX +220%
1-Year High: XXX on 2025-06-27
1-Year Low: X on 2025-03-30
Sentiment: XX% #
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -XX%
1 Month: XXX% no change
6 Months: XXX% +3%
1 Year: XXX% +54%
1-Year High: XXX% on 2024-08-06
1-Year Low: X% on 2024-08-02
Most Supportive Themes
- Positive Sentiment: (49%) High positive sentiment is present surrounding Celldex Therapeutics (CLDX), particularly regarding its potential in urticaria and positive assessments.
- Potential in Urticaria: (49%) There is significant discussion about Celldex Therapeutics (CLDX) and its potential in the chronic urticaria market.
Most Critical Themes
- Market Concerns: (2%) Concerns about market performance and valuation are present in the discussion.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XX | XX% | XXX | XX% | X | X% |
| X | X% | X | X% | X | X% | |
| Total | XX | XX% | XXX | XX% | X | X% |
Social Dominance: XXXXXXX% #
Social Dominance 24-Hour Chart Data
Current Value: XXXXXXX%
Daily Average: XXXXX%
1 Week: XXXXXXX% +0.00429%
1 Month: XXXXX% -XXXXX%
6 Months: XXXXX% +0.009%
1 Year: XXXXX% +0.0063%
1-Year High: XXXXX% on 2024-09-26
1-Year Low: XXXXXX% on 2025-07-21
Market Dominance: XXXXXXX% #
Market Dominance 24-Hour Chart Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2024-09-07
1-Year Low: XXXXXXX% on 2025-07-28
Market Cap: $XXXXXXXXXXXXX #
Market Cap 24-Hour Chart Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXX +$4.20%
1 Month: $XXXXXXXXXXXXX +$15%
6 Months: $XXXXXXXXXXXXX -$5.10%
1 Year: $XXXXXXXXXXXXX -$47%
1-Year High: $XXXXXXXXXXXXX on 2024-09-04
1-Year Low: $XXXXXXXXXXXXX on 2025-04-08
Top assets mentioned In the posts about Celldex Therapeutics, Inc in the last XX hours
Blueprint Medicines Corporation (BPMC) Bit Digital, Inc. (BTBT) Omnicom Group Inc. (OMC) Digital Realty Trust Inc (DLR) Johnson & Johnson (JNJ) Alnylam Pharmaceuticals, Inc. (ALNY) Akropolis (AKRO) Regeneron Pharmaceuticals Inc (REGN) Incyte Corporation (INCY)
Top topics mentioned In the posts about Celldex Therapeutics, Inc in the last XX hours
$jspr, $ctxr, $cris, $clvs, $cpsh, cnc, qqq, stocks, spx, amgn, $cei, cbat, $vrdn, gme, $bpmc, $goos, $hlf, $vrnt, $xpof, celc, $cdlx, nrix, ndra, vera, investment, jnj, manat, crcl, msft, spy, corz, djt, algs, soc, $7240t, norwegian krone, $prme, $btbt, coins ai, riv, scor, $sounw, $ineo, $tyra, $stro, $rlay, virt, occ, $cgen, $ubxg, bsx, hum, $ys, exp, $omc, $muln, $crgo, $civb, adp, $oec, $jrs, $crws, $dlr, $14b, $46m, amc, pdsb, $tril, $imab, $ipha, $jnj, $glpg, $atxs, sln, $syre, $rckt, telo, $tlsa, $atha, $optt, $cmps, rick, $eonr, $rick, $vyne, $zybt, sats, slb, $311k, $751k, $295k, sny, covid19, gamechanger, alb, dfdv, ter, amt, hei, $ckx
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$CLDX may go from one to another. perhaps from XX to 29"
@iTraderCharts on X 2025-07-27 00:57:56 UTC 3291 followers, XXX engagements
"$MVCO 5-Day Performance of +12.50% #bullish weekly analysis @metavesco @CRyanSchadel @StockFXz +/- SMA(50) XXXXXX (+12.50%) XX Day RSI at XX% .0012 Pivot Point 2nd Level Resistance .0011 @o_otcmprofiler @OTCMarkets @newgoldenage6 Trending: $AABB $ABML $ALPP $AMRS $APRN $AQMS $AUMN $AXAS $BCRX $BIMI $BLNK $BRTX $CANO $CBAT $CEI $CLDX $CLVS $CPSH $CRIS $CTXR"
@CrusaderStocks on X 2025-07-25 18:00:34 UTC 4359 followers, XXX engagements
"$CLDX doing well. As I mentioned before: Huge interest in #KIT inhibition - $BPMC $DCPH taken out. #Celldex could be the next target multiple opportunities in the KIT space (Discl. I own shares)"
@doepke_michel on X 2025-07-24 13:08:53 UTC 4936 followers, 1097 engagements
"$MVCO Marching back up towards it's key long term target .0009 x .001 HOW .0011 L2 is starting to turn up .0012 looks to be next resistance thin to .002's. @metavesco @CRyanSchadel @StockFXz @newgoldenage6 Trending: $AABB $ABML $ALPP $AMRS $APRN $AQMS $AUMN $AXAS $BCRX $BIMI $BLNK $BRTX $CANO $CBAT $CEI $CLDX $CLVS $CPSH $CRIS $CTXR"
@CrusaderStocks on X 2025-07-24 12:34:05 UTC 4361 followers, XXX engagements